BertEmilJohanssonMDPhD

PubMed

• 2 citations
  Deadly Mass Shootings, Mental Health, and Policies and Regulations: What We Are Obligated to Do!
  Marie Leiner, Izul De la Vega, Bert Johansson> ;Frontiers in Pediatrics. 2018 Apr 16
• 1 citations
  Fear of Massive Deportations in the United States: Social Implications on Deprived Pediatric Communities
  Marie Leiner, Izul De la Vega, Bert Johansson> ;Frontiers in Pediatrics. 2017 Aug 21
• Emergency Medical Service Personnel Recognize Pediatric Concussions
  Joshua N Speirs, Matthew I Lyons, Bert Johansson> ;Global Pediatric Health. 2017 Jul 13
• Case 3: Acute Onset of Headache, Fever, and Right Arm Weakness in 12-year-old Boy.
  Venkata Sushma Chamarthi, Sastry Chamarthi, Bert E. Johansson> ;Pediatrics in Review. 2015 Oct 1
• 44 citations
  Influenza viral neuraminidase: the forgotten antigen
  Bert E Johansson, Manon M.J. Cox> ;Expert Review of Vaccines. 2011 Dec 1
• 15 citations
  Recombinant Influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterova...
  Bert E. Johansson, Ian C. Brett> ;Human Vaccines. 2008 Nov 1
• 34 citations
  A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A.
  Julie A. McMurry, Bert E. Johansson, Anne S. De Groot> ;Human Vaccines. 2008 Mar 1
• 56 citations
  Changing perspective on immunization against influenza
  Bert E. Johansson, Ian C. Brett> ;Vaccine. 2007 Apr 20
• An inactivated subvirion influenza A (H5N1) vaccine.
  Bert E Johansson, Ian C Brett> ;The New England Journal of Medicine. 2006 Jun 22
• An inactivated subvirion influenza A (H5N1) vaccine.
  Daniele Focosi> ;The New England Journal of Medicine. 2006 Jun 22
• 69 citations
  Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neurami...
  Ian C. Brett, Bert E. Johansson> ;Virology. 2005 Sep 1
• Variation in the divalent cation requirements of influenza a virus N2 neuraminidases.
  Bert E Johansson, Ian C Brett> ;Journal of Biochemistry. 2003 Sep 1
• 93 citations
  The total influenza vaccine failure of 1947 revisited: Major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic
  Edwin D. Kilbourne, Catherine C. Smith, Ian C. Brett, Barbara A. Pokorny, Bert E. Johansson, Nancy J. Cox> ;Proceedings of the National Academy of Sciences of the United States of America. 2002 Aug 6
• 38 citations
  Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition.
  Bert E. Johansson, Barbara A. Pokorny, Vincent A Tiso> ;Vaccine. 2002 Feb 22
• 69 citations
  Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to...
  Bert E Johansson> ;Vaccine. 1999 Apr 9
• 86 citations
  Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response
  Bert E. Johansson, James T. Matthews, Edwin D. Kilbourne> ;Vaccine. 1998 May 1
• 26 citations
  Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
  Bert E. Johansson, Edwin D. Kilbourne> ;Virology. 1996 Nov 1
• 25 citations
  Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants
  Bert E. Johansson, Peter M. Price, Edwin D. Kilbourne> ;Vaccine. 1995 Jan 1
• 78 citations
  Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans
  Edwin D. Kilbourne, Robert B. Couch, Julius A. Kasel, Wendy A. Keitel, Thomas R. Cate, John H. Quarles, Bemardo Grajower, Barbara A. Pokorny, Bert E. Johansson> ;Vaccine. 1995 Jan 1
• 11 citations
  Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants.
  Edwin D. Kilbourne, Bert E. Johansson, Thomas M. Moran, S. Wu, Barbara A. Pokorny, Xiyan Xu, Nancy J. Cox> ;The Journal of General Virology. 1993 Jul 1
• 71 citations
  Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice
  Bert E. Johansson, Bernardo Grajower, Edwin D. Kilbourne> ;Vaccine. 1993 Jan 1
• 6 citations
  Influenza vaccine strain selection: equivalence of two antigenically distinct haemagglutinin variants of 1989 H3N2 influenza A virus in protection of mice.
  Bert E. Johansson, Edwin D. Kilbourne> ;Vaccine. 1992 Jan 1
• 8 citations
  Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection.
  Bert E. Johansson, Edwin D. Kilbourne> ;Journal of Virological Methods. 1991 Nov 1
• 9 citations
  Programmed antigenic stimulation: kinetics of the immune response to challenge infections of mice primed with influenza inactivated whole virus or neuraminidase vaccine.
  Bert E. Johansson, Edwin D. Kilbourne> ;Vaccine. 1991 May 1
• 23 citations
  Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.
  Bert E. Johansson, Edwin D. Kilbourne> ;The Journal of Infectious Diseases. 1990 Oct 1
• Join now to see all